These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36499616)

  • 1. Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies.
    Ali E; Trailin A; Ambrozkiewicz F; Liška V; Hemminki K
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
    Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY
    Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated hepatic stellate cells promote angiogenesis in hepatocellular carcinoma by secreting angiopoietin-1.
    Lin N; Meng L; Lin J; Chen S; Zhang P; Chen Q; Lin Y
    J Cell Biochem; 2020 Feb; 121(2):1441-1451. PubMed ID: 31609020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quiescent hepatic stellate cells induce toxicity and sensitivity to doxorubicin in cancer cells through a caspase-independent cell death pathway: Central role of apoptosis-inducing factor.
    Das D; Fayazzadeh E; Li X; Koirala N; Wadera A; Lang M; Zernic M; Panick C; Nesbitt P; McLennan G
    J Cell Physiol; 2020 Sep; 235(9):6167-6182. PubMed ID: 31975386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX; Liao R; Pan L; Du CY
    Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids.
    Song Y; Kim SH; Kim KM; Choi EK; Kim J; Seo HR
    Sci Rep; 2016 Nov; 6():36750. PubMed ID: 27853186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.
    Li ZQ; Wu WR; Zhao C; Zhao C; Zhang XL; Yang Z; Pan J; Si WK
    Int J Mol Med; 2018 Mar; 41(3):1518-1528. PubMed ID: 29286082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis.
    Li Z; Wang F; Li Y; Wang X; Lu Q; Wang D; Qi C; Li C; Li Z; Lian B; Tian G; Gao Z; Zhang B; Wu J
    Biomaterials; 2021 Sep; 276():121003. PubMed ID: 34273686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat hepatic stellate cells alter the gene expression profile and promote the growth, migration and invasion of hepatocellular carcinoma cells.
    Wang ZM; Zhou LY; Liu BB; Jia QA; Dong YY; Xia YH; Ye SL
    Mol Med Rep; 2014 Oct; 10(4):1725-33. PubMed ID: 25109274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
    Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
    BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.
    Xia Y; Zhen L; Li H; Wang S; Chen S; Wang C; Yang X
    Cell Death Dis; 2021 Mar; 12(4):326. PubMed ID: 33771969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
    Carloni V; Luong TV; Rombouts K
    Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
    Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
    J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
    Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
    Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
    Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
    Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
    Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
    Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma.
    Ruan Q; Wang H; Burke LJ; Bridle KR; Li X; Zhao CX; Crawford DHG; Roberts MS; Liang X
    Int J Cancer; 2020 Sep; 147(6):1519-1527. PubMed ID: 32010970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma.
    Ji J; Eggert T; Budhu A; Forgues M; Takai A; Dang H; Ye Q; Lee JS; Kim JH; Greten TF; Wang XW
    Hepatology; 2015 Aug; 62(2):481-95. PubMed ID: 25833323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver.
    Ma T; Wang Z; Yang Z; Chen J
    Mol Med Rep; 2015 Jul; 12(1):111-8. PubMed ID: 25738354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.